Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
暂无分享,去创建一个
S. Watson | S. Charlton | D. Sykes | J. Reilly | D. Sandham | G. Dubois | E. Willard | Asadh Miah | C. Bauer | Darren M. Riddy | Michelle E. Bradley